Differential ontogenesis of three DOI-induced behaviors in mice

Physiology and Behavior

Volumn 60, Issue 6, 1996, Pages 1495-1500

  Darmani, Nissar A ^a   Shaddy, James ^b   Gerdes, Charles F ^a  

^a A T STILL UNIVERSITY   (United States)

^b TRUMAN STATE UNIVERSITY   (United States)

Author keywords

5 HT(2A) receptor; DOI; Ear scratch response; Head twitch response; Locomotor activity; Ontogeny

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; CONTROLLED STUDY; FEMALE; HEAD TWITCH; LOCOMOTION; MALE; MATURATION; MOUSE; NONHUMAN; ONSET AGE; ONTOGENY; PRIORITY JOURNAL;

EID: 0030561554     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(96)00323-X     Document Type: Article

References (38)

1. Arevalo R., Afonso D., Castro R., Roderiguez M. Fetal brain serotonin synthesis and catabolism is under control by mother intake of tryptophan. Life Sci. 49:1991;53-66.
2. Arranz B., Erickson A., Mellerup E., Plenge P., Marcusson J. Effect of aging in human cortical pre and postsynaptic serotonin binding sites. Brain Res. 620:1993;163-166.
3. Berendsen H.H.G., Broekkamp C.L.E. Age dependence of 5-methoxytryptamine-induced hindlimb scratching in rats. Eur. J. Pharmacol. 199:1991;107-109.
4. 1D-like receptor involved in serotonergic induced hindlimbs scratching in rats. Eur. J. Pharmacol. 194:1991;201-208.
5. Boess F.G., Martin I.L. Molecular biology of 5-HT receptors. Neuropharmacology. 33:1994;275-317.
6. Carlsson M., Carlsson A. In vivo evidence for a greater brain tryptophan hydroxylase capacity in female than in male rats. Naunyn-Schmied. Arch Pharmacol. 338:1988;345-349.
7. Claustre Y., Rouquier L., Scatton B. Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat. J. Pharmacol. Exp. Ther. 244:1988;1051-1056.
8. Crockroft S. Polyphosphoinositide phosphodiesterase: regulation by a novel guanine nucleotide binding protein. Gp. Trends Biochem. Sci. 12:1987;75-78.
9. Darmani N.A. Further evidence for enigmas in adaptation mechanisms for the DOI-induced behaviors. Pharmacol. Biochem. Behav. 43:1992;765-770.
10. Darmani N.A., Gerdes C.F. Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI. Pharmacol. Biochem. Behav. 50:1995;545-550.
11. 2 receptors? Pharmacol. Biochem. Behav. 36:1990;901-906.
12. 2-receptor interactions. Pharmacol. Biochem. Behav. 37:1990;95-99.
13. Darmani N.A., Martin B.R., Glennon R.A. Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin. J. Pharmacol. Exp. Ther. 262:1992;692-698.
14. 1C-mediated phenomenon. Pharmacol. Biochem. Behav. 48:1994;383-396.
15. 1A receptor antagonist S-(-)UH 301 produces head-twitches in mice. Pharmacol. Biochem. Behav. 55:1996;1-10.
16. Eble J.P., Goodrich C. The maturational onset of the 5-HT mediated head twitch in mice. Physiol. Behav. 41:1987;47-51.
17. 2 receptors mediate discrete behaviors in the Mongolian gerbil. Pharmacol. Biochem. Behav. 43:1992;131-137.
18. 1A agonist 8-OH DPAT. J. Neural Trans. Gen. Sect. 79:1990;93-101.
19. Ike J., Canton H., Sanders-Bush E. Developmental switch in the hippocampal serotonin receptor linked to phosphoinositide hydrolysis. Brain Res. 678:1995;49-54.
20. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Revs. 72:1992;165-229.
21. 2C/2B receptor antagonist. Br. J. Pharmacol. 111:1994;792-802.
22. Lucki I., Ward H.R., Frazer A. Effect of 1-(m-chlorophenyl) piperazine and 1-(m-trifluoromethylphenyl) piperazine on locomotor activity. J. Pharmacol. Exp. Ther. 249:1989;155-164.
23. Marcusson J., Oreland L., Winbald B., Finch C.F. Serotonin-2 binding sites in human frontal cortex and hippocampus:selective loss of S-2A sites with age. Brain Res. 311:1984;51-56.
24. Martin G.R., Humphrey P.P.A. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology. 33:1994;261-273.
25. Mittman S.M., Geyer M.A. Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and proprandol. Psychopharmacology. 195:1991;69-76.
26. 2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology. 100:1990;417-425.
27. 2 receptor immunoreactivity in the developing rat brain. Neuroscience. 55:1993;869-880.
28. 2 receptors in the rat brain: Neurochemical identification of cell types by immunocytochemistry. Neuropsychopharmacology. 11:1994;157-166.
29. 2A receptor binding, but not in benzodiazepine receptor binding in the rat brains of aged rats. Life Sci. 55:1994;1585-1593.
30. 1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenylaminopropane)-2 (DOI). Neurosci. Lett. 115:1990;74-80.
31. 2 receptor antagonist. J. Pharmacol. Exp. Ther. 262:1992;759-768.
32. 1C mRNA and receptor levels. Dev. Brain Res. 58:1991;51-58.
33. 1A agonists. J. Pharmacol. Exp. Ther. 273:1995;101-112.
34. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. J. Pharmacol. Exp. Ther. 266:1993;684-691.
35. Wing L.L., Tapson G.S., Geyer M.A. 5-HT-2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology. 100:1990;417-425.
36. Yocca F.D., Wright R.N., Margraf R.R., Eison A.S. 8-OH DPAT and buspirone analogs inhibit the ketanserin sensitive quipazine-induced head-shake response in rats. Pharmacol. Biochem. Behav. 35:1990;1-4.
37. Zar, J.H. Biostatistical analysis. Englewood Cliffs, NJ: Prentice Hall Inc.; 1984.
38. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-458.